GHMAP Insights
Clear, practical writing on regulatory pathways, country entry sequencing, and partner decisions — without hype or approval promises. Fortune 500-grade rigor, operator-written.
How AI-enabled medical devices and SaMD get registered worldwide in 2026: FDA's PCCP pathway, EU MDR Rule 11 plus the AI Act, UK MHRA, ASEAN reliance routes, and the reimbursement question nobody can skip.
Archive
Each piece is written for a specific market-entry decision, and states where professional review is still required. Editorial standards inspired by McKinsey Insights and Deloitte.
How the FDA 510(k) pathway works in 2026: substantial equivalence, predicate strategy, Traditional vs Special vs Abbreviated 510(k)s, eSTAR submission, timelines, and the QMSR changes every submitter must handle.
How FDA Premarket Approval works in 2026: clinical evidence expectations, the original PMA process, supplements, advisory panels, timelines, and when PMA is avoidable — the complete Class III guide.
How the FDA De Novo pathway works in 2026: when a novel device needs De Novo instead of 510(k), direct vs post-NSE routes, the evidence bar, special controls, timelines, and how a granted De Novo becomes the predicate.
How EU Class III medical device registration works under the MDR: Annex VIII classification rules, the Annex IX notified body route, clinical evidence and expert-panel scrutiny, realistic timelines, quote-based costs, and post-market duties.
Before “The Honey Professor,” there was a gene-therapy Ph.D. student, a Honey Research Center directorship in Samsun, and a $2.8M USDA program in Texas. The career journey behind Dr. Ferhat Öztürk's honey science — in his institutions' own records.
Dr. Ferhat Öztürk's program has screened hundreds of honey samples for bioactivity — and the central finding is simple: honeys differ. What “variety” means in the lab, why Manuka is the reference standard, and what comparative research actually shows.
A jar of honey is not a medical product. Dr. Ferhat Öztürk's research asks what makes honey medical-grade — and the FDA's answer runs through the 510(k) pathway, product code FRO, and a line of MEDIHONEY precedents. The regulatory road from hive to hospital.
Dr. Ferhat Öztürk's 2025 TEDx talk distills twelve years of honey research into one thesis: honey's healing reputation can be tested, measured, and standardized. Seven ideas from “Honey, A Sweet Medicine” — and what they mean for market access.
A practical guide for small and mid-size manufacturers: where German distributors actually operate, how to find them, what to verify before signing, and what EU MDR expects from the distributor role.
A stage-by-stage planning view of German medical device market entry cost and timing—from CE readiness and Notified Body assessment through distributor onboarding, hospital evaluation, reimbursement, and launch.
Regulatory clearance or CE marking answers whether you may sell. Medical device reimbursement—coding, coverage, and payment—answers whether anyone can sustainably buy. Most small manufacturers budget for the first and discover the second too late.
A practical EU-entry path for Turkish medical device manufacturers: CE Mark under EU MDR, authorized representative (EC REP), technical file readiness, distributor sequencing, and common export mistakes.
A Certificate of Free Sale (CFS) is often requested late in an export deal. This guide explains what a CFS proves, who typically issues it, how it differs from CE or ISO certificates, and why lead time matters.
A distributor-ready pack beats a pitch deck alone: regulatory status, technical documentation, ISO 13485, free-sale/export documents, and a clear commercial package—assembled before the first meeting.
How Kenya medical device registration works with the Pharmacy and Poisons Board (PPB): device classes, Local Authorized Representative rules, evaluation routes, official fees, real-world timelines, and post-market duties.
You can build a medical device launch plan yourself. This article shows what that work actually includes—and when a reviewed Market Entry Sprint is worth the time and money.
An illustrative, composite walkthrough of wound care device market entry—from first-market choice and regulatory pathway through documentation, distributors, hospital pilots, reimbursement questions, and launch.
A practical comparison of the European CE Mark path under EU MDR and the U.S. FDA 510(k) clearance route—so small and mid-size manufacturers can choose a first market with clearer trade-offs.
In 2025, researchers including Dr. Ferhat Öztürk published a consensus definition of “medical-grade honey.” Organic sourcing, gamma sterilization, measured potency — what the standard requires and why each element matters.
Honey is one of the most adulterated foods on earth — a problem for shoppers and a dealbreaker for medicine. How laboratories test authenticity, and where Dr. Ferhat Öztürk's large-scale honey screening fits into the picture.
The HONEY Pathway — “Honeybee Oriented Nextgen Entrepreneurs and Youth” — pairs a $2.8M USDA grant with student scientists and urban beekeepers. How Dr. Ferhat Öztürk built a pipeline of people behind the science of medicinal honey.
Burns are among the oldest recorded uses of honey — and Dr. Ferhat Öztürk's 2024 systematic review gathered 38 studies on exactly this question. What the evidence shows, what “medical-grade” means, and how a burn dressing reaches the market.
Dr. Ferhat Öztürk's 2025 Antibiotics paper put honey compounds to the test in rigorous antibacterial assays. A look at the lab methods behind honey's antibacterial reputation — and why the antibiotic-resistance era gives this old remedy new relevance.
Dr. Ferhat Öztürk has spent 12+ years studying honey's antibacterial and wound-healing properties — leading a $2.8M USDA research program, co-authoring peer-reviewed standards for medical-grade honey, and taking the science to a TEDx stage. The science, the standards, and the market path.
Reviewed launch planning
GHMAP structures source status, evidence gaps, review needs, and next actions for the markets you are evaluating.
Professional review is required before business use.
